Overview and Scope
Anti-aging drugs are a type of medication or supplement that is designed to slow down or reverse the aging process. It addresses the root causes of aging and seeks to heal any age-related illness.
Sizing and Forecast
The anti-aging drugs market size has grown strongly in recent years. It will grow from $53.76 billion in 2023 to $57.85 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in chronic diseases associated with aging, increasing awareness of aging-related health issues, regulatory support for aging research, consumer focus on wellness and longevity.
The anti-aging drugs market size is expected to see strong growth in the next few years. It will grow to $77.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of senolytic drugs, collaborations and partnerships in research, regulatory pathways for aging therapeutics, increased consumer adoption of anti-aging interventions. Major trends in the forecast period include targeted therapies and personalized medicine, senolytic drugs for cellular senescence, gene therapy and crispr technologies, focus on mitochondrial health, microbiome modulation for longevity.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/anti-aging-drugs-global-market-report
Segmentation & Regional Insights
The anti-aging drugs market covered in this report is segmented –
1) By Product: Serums, Creams, Gels, Other Products
2) By Drug Class: Hormonal Therapy, Antioxidants, Enzymes, Stem Cells
3) By Type: Injectable, Oral, Topical
4) By Ingredient: Retinoid, Hyaluronic Acid, Alpha Hydroxy Acid, Other Ingredients
5) By Drug Application: Skin And Hair, Skeletal And Muscles, Age Related Disorders, Other Applications
North America was the largest region in the anti-aging drugs market in 2023. The regions covered in the anti-aging drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10231&type=smp
Major Driver Impacting Market Growth
The rise in the aging population is expected to propel the growth of the anti-aging drugs market going forward. The rise in the aging population refers to the increase in the proportion of older adults aged 60 years or more as compared to other age groups within a population. This demographic shift has resulted from advances in healthcare that lead to a longer lifespan, declining fertility rates, and changes in social and economic structures. Anti-aging medications are used to increase a human being’s healthy lifetime who still exhibits youthful traits. For instance, in October 2022, according to World Health Organization a Switzerland-based international public health organization, By 2030, one out of every six persons in the globe will be over the age of 60, and by 2020, the number of elderly people will have increased by 1 billion to 1.4 billion. Moreover, according to Eurostat database, a statistical office of the European Union, older persons (aged 65 and above) made up 21.1% of the population (a 0.3 % point (pp) rise from the previous year and a 3.1% pp increase from ten years ago). Therefore, the rise in the aging population is driving the growth of the anti-aging drugs market.
Key Industry Players
Major companies operating in the anti-aging drugs market report are L’Oréal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sanofi S.A., Elysium Health Inc., Estée Lauder Companies Inc., AbbVie Inc., La Roche-Posay, Nu Skin Enterprises Inc., Dermafix Biotech Private Limited, The Procter & Gamble Company, Johnson & Johnson Services Inc., Sun Pharmaceutical Industries Ltd., BioTime Inc., PT. Daewoong Pharmaceutical Co. Ltd., Allergan plc, Daewoong Pharmaceutical Co. Ltd., MMJ PhytoTech Limited, Revitacare, SciVision Biotech, Canbex Therapeutics Ltd., Lumenis Ltd., Cynosure Inc., Age Sciences Inc., ALMA LASERS Ltd., Bausch Health Companies Inc., Hansen Supplements, Ponce De Leon Health Inc. , Youth & Earth, Vitality Pro
The anti-aging drugs market report table of contents includes:
1. Executive Summary
2. Anti-Aging Drugs Market Characteristics
3. Anti-Aging Drugs Market Trends And Strategies
4. Anti-Aging Drugs Market – Macro Economic Scenario
5. Global Anti-Aging Drugs Market Size and Growth
….
31. Global Anti-Aging Drugs Market Competitive Benchmarking
32. Global Anti-Aging Drugs Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Anti-Aging Drugs Market
34. Anti-Aging Drugs Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
